99mtc ec20
Small moleculeexperimentalImaging agent
Clinical trial activity
14 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
9
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2000 (NCT01689636)
Timeline
Indications
Studied for
- Arthritis, Rheumatoid · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Renal Cell · Phase 2
- Crohn Disease · Phase 2
- Endometrial Neoplasms · Phase 2
- Head and Neck Neoplasms · Phase 2
- Healthy Volunteers · Phase 1
- Lupus Erythematosus, Systemic · Phase 2
- Multiple Sclerosis · Phase 2
- Neoplasm Metastasis · Phase 2
- Neoplasms · Phase 1
- Osteoarthritis · Phase 2
- Ovarian Neoplasms · Phase 3
- Pancreatic Neoplasms · Phase 2
- Pituitary Neoplasms · Phase 2
- Testicular Neoplasms · Phase 2
- Urinary Bladder Neoplasms · Phase 2
Mechanism of action
- Folate receptor alphaBINDING AGENT
FOLR1 binding agent
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc ec20
- 99mtc-ec20
- ec20
- ec20
- folatescan
- tc 99m ec20
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01999738 | Phase 1 | Oct 1, 2013 | Endocyte |
| NCT01170650 | Phase 3 | Apr 1, 2011 | Endocyte |
| NCT01577654 | Phase 2 | Mar 1, 2011 | Endocyte |
| NCT00852189 | Phase 1 | Apr 1, 2009 | Endocyte |
| NCT00722592 | Phase 2 | Sep 1, 2008 | Endocyte |
| NCT00441870 | Phase 1 | Feb 1, 2007 | Endocyte |
| NCT00588393 | Phase 2 | Sep 1, 2006 | Endocyte, Mayo Clinic |
| NCT01689766 | Phase 2 | Nov 1, 2003 | Endocyte |
| NCT01689714 | Phase 2 | Aug 1, 2003 | Endocyte, Mayo Clinic |
| NCT01684098 | Phase 2 | Aug 1, 2003 | Emory University, Endocyte |
| NCT01689727 | Phase 2 | Sep 1, 2002 | Emory University, Endocyte |
| NCT01689662 | Phase 2 | Aug 1, 2002 | Endocyte |
| NCT01686256 | Phase 1 | Aug 1, 2001 | Endocyte, Indiana University |
| NCT01689636 | Phase 1 | Aug 1, 2000 | Endocyte |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Endocyte | For profit | 14 | 13 | 3 | 2000 |
| Emory University | Academic/Hospital | 2 | 0 | 1 | 2002 |
| Mayo Clinic | Academic/Hospital | 2 | 1 | 1 | 2003 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2001 |
4 organizations
Page 1 / 1